Category: Glucose monitor

Medgraph sues Medtronic over glucose monitor patent

December 11, 2009 by MassDevice staff

A relative bantam is stepping into the patent infringement ring with one of the industry's heavyweights.

Medgraph Inc., a Rochester, N.Y.-based telemedicine firm, sued Medtronic Inc. (NYSE:MDT), accusing the Minneapolis medical device monolith of patent infringement for its Carelink diabetes management system.

Echo Therapeutics gears up for investor push

December 10, 2009 by MassDevice staff

Echo Therapeutics Inc. (OTC:ECTE) is gearing up for a push to land new investors next year, which it expects to be "transformative," hiring a New York-based investor relations consulting firm to manage a "strategic investor relations campaign."

Hayden IR will develop and implement the Franklin, Mass.-based company's bid to attract more investors in 2010. Echo is developing needle-free drug delivery technologies, including a non-invasive, wireless glucose monitoring device and skin preparation system for transdermal drug delivery.

Echo Therapeutics scores an extra $562,000 in Philly

December 4, 2009 by MassDevice staff

Echo Therapeutics Inc. (OTCBB:ECTE) wrapped up its latest fund-raising effort this week, tapping into the old-money network in and around the City of Brotherly Love.

Echo Therapeutics releases positive glucose monitor study results

November 19, 2009 by MassDevice staff

Echo Therapeutics Inc. (ECTE) is touting preliminary results of a clinical trial of its Symphony tCGM Biosensor glucose monitor in patients with Type I and Type II diabetes.

Echo Therapeutics drums up $3 million

November 13, 2009 by MassDevice staff

Echo Therapeutics Inc. (ECTE) drummed up about $3 million in a private stock sale.

The Franklin, Mass.-based company, which is developing a non-invasive, wireless transdermal continuous glucose monitoring system, said it sold roughly 2.37 million share for $1.25 each, and issued about 2.2 million warrants with a $2.00 exercise price.

Echo Therapeutics begins clinical study of transdermal glucose monitor

November 4, 2009 by MassDevice staff

Echo Therapeutics Inc. will complete a clinical study of its Symphony non-invasive, wireless transdermal continuous glucose monitoring system by the fourth quarter, in what would be a major step forward for a company that has burned through more than $60 million trying to bring its products to market.